25.02.2013 Views

Mark J. Eisenberg, MD MPH FACC FAHA 5

Mark J. Eisenberg, MD MPH FACC FAHA 5

Mark J. Eisenberg, MD MPH FACC FAHA 5

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

5/1/2012<br />

23<br />

<strong>Mark</strong> J. <strong>Eisenberg</strong>, <strong>MD</strong> <strong>MPH</strong> <strong>FACC</strong> <strong>FAHA</strong><br />

91. *Goldman LE, Okrainec K, <strong>Eisenberg</strong> MJ, Schechter D, Lefkovits J, Goudreau E,<br />

Deligonul U, Mak KH, Del Core M, Duerr R, Huynh T, Smilovitch M, Sedlis S, Brown<br />

DL, Brieger D; ROSETTA Investigators. Six month outcomes after single and multilesion<br />

percutaneous coronary intervention: Results from the ROSETTA Registry. Can J<br />

Cardiol 2004; 20:608-12.<br />

92. <strong>Eisenberg</strong> MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Duerr R,<br />

Del Core M, Garzon P, Huynh T, Smilovitch M, Sedlis S, Brown DL, Brieger D, Pilote<br />

L. Utility of routine functional testing after percutaneous transluminal coronary<br />

angioplasty: Results from the ROSETTA Registry. J Inv Cardiol 2004; 16:318-22.<br />

93. Mak KH, <strong>Eisenberg</strong> MJ, Tsang J, Okrainec K, Huynh T, Brown D. Clinical impact of<br />

functional testing strategy among stented and non-stented patients: Insights from the<br />

ROSETTA Registry. Int J Cardiol 2004; 95:321-7.<br />

94. *Okrainec K, Banerjee DK, <strong>Eisenberg</strong> MJ. Coronary artery disease in the developing<br />

world. Am Heart J 2004; 148:7-15.<br />

95. *Jamal SM, <strong>Eisenberg</strong> MJ, Christopoulos S. Rhabdomyolysis associated with<br />

hydroxymethylglutaryl-coenzyme A reductase inhibitors. Am Heart J 2004; 147:956-65.<br />

96. Pilote L, Abrahamowicz M, Rodrigues E, <strong>Eisenberg</strong> MJ, Rahme E. Mortality rates in<br />

elderly patients who take angiotensin-converting enzyme inhibitors after acute<br />

myocardial infarction: A class effect? Ann Intern Med 2004; 141:101-12.<br />

97. Antoniou J, Martineau P, Filion KB, Haider S, Zukor D, Huk O, Pilote L, <strong>Eisenberg</strong> MJ.<br />

In-hospital costs of total hip arthroplasty in Canada and the United States. J Bone Joint<br />

Surg Am 2004; 86:2435-9.<br />

98. *Babapulle MN, Joseph L, Bélisle P, Brophy JM, <strong>Eisenberg</strong> MJ. A hierarchical<br />

Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004;<br />

364:583-91.<br />

99. <strong>Eisenberg</strong> MJ. Drug-eluting stents: Some bare facts. Lancet 2004; 364:1466-7.<br />

100. *Okrainec K, Platt R, Pilote L, <strong>Eisenberg</strong> MJ. Cardiac medical therapy in patients<br />

undergoing coronary artery bypass graft surgery: A review of randomized controlled<br />

trials. J Am Coll Cardiol 2005; 45:177-84.<br />

101. *Saririan M, Cugno S, Blankenship J, Huynh T, Pilote L, Wilson B, <strong>Eisenberg</strong> MJ.<br />

Routine versus selective functional testing after percutaneous coronary intervention in<br />

patients with diabetes mellitus. J Inv Cardiol 2005; 17:25-9.<br />

102. *Gioia LC, Filion KB, Haider S, Pilote L, <strong>Eisenberg</strong> MJ. Hospital readmissions<br />

following abdominal aortic aneurysm repair. Ann Vasc Surg 2005; 19:35-41.<br />

103. *Buresly K, <strong>Eisenberg</strong> MJ, Zhang X, Pilote L. Bleeding complications associated with<br />

combinations of aspirin, thienopyridine derivatives and warfarin in elderly patients<br />

following acute myocardial infarction. Arch Intern Med 2005; 165:784-9.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!